Drug recall · January 25, 2023
Levofloxacin Tablets recall
Why: Mismatching of the embossing on the tablets (T7) with the embossing mentioned in the package insert (ML63) in the distributed bottles.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Levofloxacin Tablets, USP 500 mg; 50-count bottles, Rx Only, Manufactured for: Macleods Pharma USA, Inc. Princeton, NJ 08540; Manufactured by: Macleods Pharmaceuticals Ltd., Baddi, Himachal Pradesh, India. NDC 33342-022-08
- Lots / codes
Lot #: BLF2214A; Exp. 06/2025
- Quantity
- 10052 bottles
- Company
- Macleods Pharma USA, Inc, Princeton, NJ
- Distribution
- Nationwide within United States and Puerto Rico.
- Initiated
- January 5, 2023 · Voluntary: Firm initiated
- Classified
- January 17, 2023
- Reported
- January 25, 2023
- Ended
- June 24, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Levofloxacin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.